We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$4.51B
AUM Growth
+$737M
(+20%)
Cap. Flow
+$736M
Cap. Flow
% of AUM
16.32%
Top 10 Holdings %
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$99.4M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$80.7M |
| 3 |
Johnson & Johnson
JNJ
|
+$77.7M |
| 4 |
Electronic Arts
EA
|
+$61.9M |
| 5 |
Danaher
DHR
|
+$60.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$99.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$97.8M |
| 3 |
Medtronic
MDT
|
+$68.7M |
| 4 |
NXP Semiconductors
NXPI
|
+$61.6M |
| 5 |
Lumentum
LITE
|
+$58.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.83% |
| 2 | Technology | 26.25% |
| 3 | Communication Services | 6.68% |
| 4 | Consumer Discretionary | 4.05% |
| 5 | Financials | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Kymera Therapeutics
KYMR
$8.75B
| – | – |
-169,687
| Closed | -$10.5M |
|
452
Legend Biotech
LEGN
$3.73B
| – | – |
-431,418
| Closed | -$12.1M |
|
|
453
Lumentum
LITE
$65.2B
| – | – |
-620,808
| Closed | -$58.9M |
|
454
Lufax Holding
LU
$1.29B
| – | – |
-62,500
| Closed | -$3.55M |
|
455
lululemon athletica
LULU
$14.2B
| – | – |
-31,162
| Closed | -$10.8M |
|
456
Mastercard
MA
$505B
| – | – |
-150,368
| Closed | -$53.7M |
|
|
457
Medtronic
MDT
$110B
| – | – |
-586,448
| Closed | -$68.7M |
|
458
Monolithic Power Systems
MPWR
$66.8B
| – | – |
-53,328
| Closed | -$19.5M |
|
459
Nurix Therapeutics
NRIX
$2.62B
| – | – |
-161,211
| Closed | -$5.3M |
|
460
NetApp
NTAP
$37.6B
| – | – |
-374,600
| Closed | -$24.8M |
|
461
Envista
NVST
$4.46B
| – | – |
-123,855
| Closed | -$4.18M |
|
|
462
NXP Semiconductors
NXPI
$58.4B
| – | – |
-387,399
| Closed | -$61.6M |
|
463
New York Times
NYT
$10.5B
| – | – |
-140,472
| Closed | -$7.27M |
|
464
Omnicom Group
OMC
$22.6B
| – | – |
-260,234
| Closed | -$16.2M |
|
465
Procter & Gamble
PG
$342B
| – | – |
-23,039
| Closed | -$3.21M |
|
466
Perrigo
PRGO
$1.74B
| – | – |
-291,607
| Closed | -$13M |
|
467
Qualcomm
QCOM
$168B
| – | – |
-85,266
| Closed | -$13M |
|
468
Replimune Group
REPL
$1.08B
| – | – |
-54,254
| Closed | -$2.07M |
|
469
Regenxbio
RGNX
$722M
| – | – |
-48,329
| Closed | -$2.19M |
|
470
Root
ROOT
$799M
| – | – |
-77,013
| Closed | -$21.8M |
|
471
Syndax Pharmaceuticals
SNDX
$1.76B
| – | – |
-77,699
| Closed | -$1.73M |
|
472
Sensata Technologies
ST
$6.74B
| – | – |
-432,519
| Closed | -$22.8M |
|
473
Savara
SVRA
$1.19B
| – | – |
-374,904
| Closed | -$431K |
|
474
Tenet Healthcare
THC
$20.7B
| – | – |
-77,826
| Closed | -$3.11M |
|
475
TripAdvisor
TRIP
$1.21B
| – | – |
-280,000
| Closed | -$8.06M |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Woodline Partners held 501 positions worth $4.51B, up 20% from $3.77B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Woodline Partners deployed $736M of net new capital in Q1 2021, opening 284 new positions and adding to 70 existing holdings. Its largest new stake was Gilead Sciences: 1,541,893 shares worth $99.7M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Amgen, an estimated $99.3M trimmed.
- Woodline Partners's largest Q1 2021 buy was Gilead Sciences: 1,541,893 shares worth $99.7M.
- Woodline Partners added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $80.7M increase.
- Woodline Partners's biggest Q1 2021 reduction was Amgen, cutting an estimated $99.3M.
- Woodline Partners fully exited Alphabet (Google) Class A in Q1 2021, selling an estimated $97.8M.
- Woodline Partners's ten largest holdings make up 19% of its $4.51B portfolio in Q1 2021.
- Woodline Partners opened 284 new positions and closed 74 in Q1 2021.
- Woodline Partners's portfolio value rose 20% quarter-over-quarter to $4.51B.
Based on Woodline Partners's 13F filing for Q1 2021, filed 17 May 2021.